Phase-3 of Oxford covid vaccine to begin soon

October 24, 2020 12:07

The Brihanmumbai Municipal Corporation has completed the second phase of clinical trials of the Oxford-AstraZeneca Covid-19 vaccine. The civic body will soon start third phase trials after the first batch of volunteers complete 28 days since their first vaccination.

With the approval, we will be able to start the third phase of the trial once the first set of volunteers complete 28 days of the first vaccination. As per Indian Council of Medical Research, the third trial can only be conducted on volunteers after a gap of 28 days, said Suresh Kakani, additional commissioner, BMC.

On September 26, the first dosage of the second phase of trial was given to three volunteers between ages 20 and 45 years at KEM hospital. On October 23, they completed 28 days of their first vaccination.

The Pune-based Serum Institute of India has partnered with British-Swedish pharmaceutical giant AstraZeneca to manufacture the experimental Covid-19 vaccine formulated at the University of Oxford.

« Back to LIVE

TOP STORIES

After Delhi, schools in Ahmedabad get bomb threat mails

Polling in 25 Lok Sabha seats in Gujarat will be held on May 7.

Paris 2024 Olympics may face cybersecurity nightmare

Paris 2024 gearing up to face unprecedented cybersecurity threat

Every NEET paper accounted for, social media images fake, says NTA

Stressing that every question paper has been "accounted for", the NTA said that purported images of the question paper circulating on social media have no relation with the actual paper.

Jadeja's all-round show sparks T20 WC excitement

Jadeja will be expected to play a key role in the T20 showpiece in the United States and West Indies, where the ball is likely to turn.

India's first-ever hybrid pitch unveiled in Dharamsala

'Yes, the playing conditions still vary over time. But you're still in control of what sort of works for you on a pitch. So, you might play on a new hybrid pitch for one game.'